How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Bioflavonoids Market
- By Source: Citrus Fruits, Grapes, Green Tea, Onion Skins, Buckwheat
- By Form: Powder, Liquid Extract, Capsules, Tablets, Bulk Powder
- By Application: Dietary Supplements, Pharmaceuticals, Functional Foods & Beverages, Cosmetics, Animal Feed
- By End-Use Industry: Nutraceuticals, Pharmaceutical Industry, Food & Beverage Industry, Personal Care Industry, Animal Nutrition Industry
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Citrus Fruits leads By Source at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 13 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 277 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.170 →
- 11 Company Profiles 13 players: SWOT & benchmarking p.178 →
Full report · locked preview
Everything inside the Bioflavonoids Market report
A complete, evidence-based study - 11 chapters and 116 sections covering market size, segmentation across 4 axes, regional analysis and 13 company profiles, forecast to 2033.
Segmentation covered
Source 5
Form 5
Application 5
End-Use Industry 5
Companies profiled
BASF SE
DSM Nutritional Products
Indena S.p.A.
Nutraceutical Corporation
Sabinsa Corporation
Givaudan
Chr. Hansen Holding A/S
Nutribiotech International
Xi'an Sgonek Biological Technology Co. Ltd.
Shandong Jianyuan Biotechnology Co. Ltd.
Nutraceuticals International Group
Nutritional Fundamentals for Health
+1 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
13 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →BASF SE
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →DSM Nutritional Products
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Indena S.p.A.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Nutraceutical Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Sabinsa Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Givaudan
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →Chr. Hansen Holding A/S
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Nutribiotech International
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Xi'an Sgonek Biological Technology Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Shandong Jianyuan Biotechnology Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Nutraceuticals International Group
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.214 →Nutritional Fundamentals for Health
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →
Global · 2025–2033
$784.4M by 2033 · 6.1% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Citrus Fruits49.9
- Grapes13.3
- Green Tea11.7
- Onion Skins10.0
- Buckwheat15.1
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$161.8M → $265.3M · 6.4%
Europe$112.8M → $178.1M · 5.9%
Asia Pacific$102.9M → $176.7M · 7.0%
Latin America$63.7M → $95.8M · 5.2%
Middle East and Africa$49.0M → $72.2M · 5.0%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →6.012026
6.022027
6.032028
6.042029
6.052030
6.072031
6.072032
6.082033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- BASF SE20.5
- DSM Nutritional Products18.8
- Indena S.p.A.10.0
- Nutraceutical Corporation4.8
- Sabinsa Corporation9.7
- Givaudan8.2
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Source19.9%
Form22.7%
Application25.5%
End-Use Industry32.0%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.7
- Europe22.6
- Asia Pacific22.4
- Latin America12.2
- Middle East and Africa9.2
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| BASF SE | 77 | 80 | 97 | 86 | 82 | 85 | 85 |
| DSM Nutritional Products | 78 | 73 | 93 | 84 | 92 | 89 | 85 |
| Indena S.p.A. | 74 | 69 | 73 | 85 | 75 | 75 | 75 |
| Nutraceutical Corporation | 72 | 72 | 60 | 73 | 77 | 77 | 72 |
| Sabinsa Corporation | 76 | 68 | 63 | 62 | 55 | 68 | 65 |
| Givaudan | 47 | 51 | 71 | 59 | 49 | 53 | 55 |
| Chr. Hansen Holding A/S | 60 | 55 | 43 | 64 | 53 | 40 | 53 |
| Nutribiotech International | 46 | 41 | 42 | 42 | 55 | 46 | 45 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- BASF SE
- DSM Nutritional Products
- Indena S.p.A.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| BASF SE | ◐ | ◐ | ✓ | ✓ | ✓ | ◐ |
| DSM Nutritional Products | ✓ | ✓ | ✓ | ◐ | ✓ | ✓ |
| Indena S.p.A. | ◐ | ◐ | ✓ | ✓ | ◐ | ✓ |
| Nutraceutical Corporation | ◐ | ◐ | ◐ | ◐ | ◐ | ◐ |
| Sabinsa Corporation | ✓ | ◐ | − | − | − | ◐ |
| Givaudan | − | ◐ | ✓ | − | ◐ | − |
| Chr. Hansen Holding A/S | − | ◐ | − | ◐ | − | − |
| Nutribiotech International | − | − | − | − | ◐ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1BASF SE85
2DSM Nutritional Products85
3Indena S.p.A.75
4Nutraceutical Corporation72
5Sabinsa Corporation65
6Givaudan55
7Chr. Hansen Holding A/S53
8Nutribiotech International45
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
BASF SEDSM Nutritional Products
Challenger2
Strong scale, closing on the leaders.
Indena S.p.A.Nutraceutical Corporation
Contender1
Focused players with pockets of strength.
Sabinsa Corporation
Niche3
Specialists in a single segment or region.
GivaudanChr. Hansen Holding A/SNutribiotech International
Go-to-market strategy
Land Source in North America, then scale across Bioflavonoids Market — a $270M beachhead inside a $4.36B market.
Beachhead (SOM)$270Mobtainable near-term
Serviceable (SAM)$1.49Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion86 fit
Citrus Fruits
Best fit — highest urgency & budget in Source.
Economic buyer79 fit
Grapes
Strong fit — clear ROI and a fast path to value.
End user70 fit
Green Tea
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Source in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Form & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales42%
Partner / channel27%
Digital / self-serve22%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Source leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Bioflavonoids Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified43%
Sales qualified21%
Evaluation15%
Closed-won7%
$16.7KCAC
$74KLTV
4.5:1LTV : CAC
< 5 moCAC payback
Investment thesis
Bioflavonoids Market is a durable-growth opportunity — $7.17B by 2033, compounding at 8.4%.
TAM · 2025$3.77Btoday
TAM · 2033$7.17Bforecast
CAGR8.4%2027–2033
Cumulative$47.8Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$7.17BTotal addressable market
SAM$2.98BServiceable available market
SOM$539MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.4% CAGR
Demand compounds through 2033, outpacing GDP across Source.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Source moving from early to mainstream — durable secular demand.
Consolidation upside
13+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$7.17BLarge & growingTAM by 2033 at 8.4% CAGR
$2.98BServiceable nowreachable with today’s model
$539MBeachhead winobtainable near-term share
13+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.59BBear5.4% CAGR
$7.17BBase8.4% CAGR
$9.17BBull11.0% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Form optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Bioflavonoids Market — a $6.19B market by 2033. Plan: grow share from 7.0% to 13.8%.
Market size · 2033$6.19Btotal addressable
Market CAGR8.1%2027–2033
Target share13.8%from 7.0% today
Revenue ambition$855Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.0% | 13.8% | On track |
| Revenue | $472M | $855M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | Behind |
| Gross margin | 34.6% | 44.5% | Behind |
| Customer retention | 86.5% | 93.1% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Source
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Form capability
A defensible second engine — invest in Form to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Source share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Form
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $112M capacity & capability investment
- Greenlight bolt-on M&A in Form
- Authorise North America expansion plan
- Fund R&D program for Source leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeAhead
- Execution & talentAhead
Sales deck · value proposition
Win the Bioflavonoids Market conversation — a $7.15B market you can size, segment and defend in minutes.
Market size · 2033$7.15Btotal opportunity
Growth5.5%CAGR to 2033
Addressable buyers942+accounts in scope
Typical ROI6.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Source
Goal Grow share in Source
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.5×return on cost, year one
< 2 mopayback period
$40K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
13+players profiled in this market
Coverage includes
BASF SEDSM Nutritional ProductsIndena S.p.A.Nutraceutical CorporationSabinsa CorporationGivaudanChr. Hansen Holding A/SNutribiotech International+5 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Bioflavonoids Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Bioflavonoids Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Biofloc Fish Farming Tank Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportBiofuel Briquettes Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportBiofuel Energy Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportBiofuels (Biodiesel And Bioethanol) Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportBiofuels for Boiler Market
Market size, share, segmentation and regional forecast.
$465M market · 2025 base year
View reportBiogas (Agricultural) Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportBiogas Booster Fan Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportBiogas Compressor Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportBiogas Dewatering Equipment Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportBiogas Dryer Market
Market size, share, segmentation and regional forecast.
$2.0B market · 2025 base year
View reportBiogas Energy Saving Baking Oven Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportBiogas Engine Market
Market size, share, segmentation and regional forecast.
$1.0B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report ships as a formatted PDF, a fully editable XLSX containing all underlying data tables, and a presentation-ready PPT deck - so you can re-chart, re-model, or drop any figure straight into your own deck.